Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)
China · Delayed Price · Currency is CNY 116.60
-0.71 (-0.61%)
Sep 16, 2026, 3:00 PM CST
SHA:600436 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,114 | 1,256 | 1,488 | 1,159 | 2,496 | 7,097 |
Short-Term Investments | 1,530 | 1,292 | 3,520 | 9,014 | 6,202 | - |
Trading Asset Securities | - | - | - | - | - | 8.8 |
Cash & Short-Term Investments | 3,644 | 2,548 | 5,008 | 10,173 | 8,698 | 7,106 |
Cash Growth | -27.50% | -49.12% | -50.78% | 16.95% | 22.42% | 37.48% |
Accounts Receivable | 1,095 | 830.91 | 894.43 | 1,021 | 859.49 | 673.3 |
Other Receivables | 95.77 | 67.9 | 63.95 | 65.15 | 107.94 | 134.95 |
Receivables | 1,190 | 898.81 | 958.38 | 1,086 | 967.43 | 808.25 |
Inventory | 5,954 | 6,679 | 4,967 | 3,379 | 2,628 | 2,438 |
Prepaid Expenses | 71.18 | 97.28 | 12.82 | 14.05 | 4.55 | 20.68 |
Other Current Assets | 298.47 | 445.83 | 382.92 | 447.9 | 406.61 | 261.36 |
Total Current Assets | 11,158 | 10,669 | 11,329 | 15,100 | 12,705 | 10,633 |
Property, Plant & Equipment | 2,108 | 1,937 | 1,508 | 614.62 | 465.62 | 400.14 |
Long-Term Investments | 4,542 | 1,364 | 870.45 | 631.98 | 673.7 | 799.87 |
Other Intangible Assets | 340.69 | 267.49 | 273.1 | 291.09 | 319.37 | 220.96 |
Long-Term Deferred Tax Assets | 129.82 | 115.43 | 155.5 | 187.31 | 167.26 | 166.98 |
Long-Term Deferred Charges | 27.24 | 30.54 | 34.05 | 29.99 | 37.65 | 44.19 |
Other Long-Term Assets | 208.28 | 3,177 | 3,370 | 225.4 | 235.41 | 255.59 |
Total Assets | 18,514 | 17,560 | 17,540 | 17,080 | 14,604 | 12,521 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 470.75 | 547.81 | 480.01 | 667.92 | 464.9 | 386.99 |
Accrued Expenses | 352.24 | 275.91 | 485.41 | 685.98 | 345.39 | 342.14 |
Short-Term Debt | 816.98 | 838.13 | 892.79 | 989.93 | 970.96 | 775.79 |
Current Portion of Long-Term Debt | 7.6 | 7.67 | 6.99 | 1.87 | - | - |
Current Portion of Leases | 36.4 | 32.62 | 35.81 | 31.86 | 29.21 | 22.75 |
Current Income Taxes Payable | 58.33 | 5.06 | 59.07 | 142.65 | 72.93 | 108.96 |
Current Unearned Revenue | 197.28 | 269.18 | 270.81 | 237.1 | 468.57 | 326.56 |
Other Current Liabilities | 1,079 | 148.2 | 142.92 | 125.8 | 158.22 | 173.9 |
Total Current Liabilities | 3,018 | 2,125 | 2,374 | 2,883 | 2,510 | 2,137 |
Long-Term Debt | 52.28 | 56.08 | 58.15 | 35.44 | - | - |
Long-Term Leases | 120.52 | 127.66 | 154.58 | 107.29 | 108.8 | 86.67 |
Long-Term Unearned Revenue | 27.97 | 26.26 | 26.68 | 17.67 | 17.01 | 20.24 |
Pension & Post-Retirement Benefits | 52.92 | 53.17 | 53.28 | 35.04 | 34.29 | 32.23 |
Long-Term Deferred Tax Liabilities | 67.18 | 52.98 | 0.33 | 30.02 | 61.09 | 74.52 |
Other Long-Term Liabilities | 26.64 | 31.23 | 34.1 | 51.35 | 48.54 | 32.88 |
Total Liabilities | 3,366 | 2,472 | 2,701 | 3,160 | 2,780 | 2,384 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 603.32 | 603.32 | 603.32 | 603.32 | 603.32 | 603.32 |
Additional Paid-In Capital | 1,095 | 1,095 | 1,095 | 1,095 | 1,094 | 1,086 |
Retained Earnings | 12,855 | 12,709 | 12,497 | 11,602 | 9,559 | 7,816 |
Comprehensive Income & Other | 58.16 | 132.18 | 76.92 | 76.6 | 74.41 | 200.05 |
Total Common Equity | 14,611 | 14,539 | 14,272 | 13,376 | 11,330 | 9,705 |
Minority Interest | 536.61 | 548.58 | 567.01 | 544.17 | 493.97 | 432.07 |
Shareholders' Equity | 15,148 | 15,088 | 14,839 | 13,920 | 11,824 | 10,138 |
Total Liabilities & Equity | 18,514 | 17,560 | 17,540 | 17,080 | 14,604 | 12,521 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,034 | 1,062 | 1,148 | 1,166 | 1,109 | 885.21 |
Net Cash (Debt) | 2,610 | 1,486 | 3,859 | 9,007 | 7,589 | 6,220 |
Net Cash Growth | -34.01% | -61.50% | -57.15% | 18.67% | 22.01% | 39.78% |
Net Cash Per Share | 4.33 | 2.46 | 6.39 | 14.94 | 12.59 | 10.31 |
Filing Date Shares Outstanding | 603.32 | 603.32 | 603.32 | 603.32 | 603.32 | 603.32 |
Total Common Shares Outstanding | 603.32 | 603.32 | 603.32 | 603.32 | 603.32 | 603.32 |
Working Capital | 8,140 | 8,544 | 8,955 | 12,217 | 10,195 | 8,496 |
Book Value Per Share | 24.22 | 24.10 | 23.66 | 22.17 | 18.78 | 16.09 |
Tangible Book Value | 14,271 | 14,272 | 13,999 | 13,085 | 11,011 | 9,484 |
Tangible Book Value Per Share | 23.65 | 23.66 | 23.20 | 21.69 | 18.25 | 15.72 |
Buildings | 641.97 | 624.02 | 1,095 | 400.13 | 331.45 | 332.55 |
Machinery | 411.64 | 408.37 | 368.02 | 345.33 | 324.4 | 300.25 |
Construction In Progress | 1,419 | 1,248 | 314.85 | 157.19 | 60.78 | 14.94 |